Page last updated: 2024-10-31

metoclopramide and Hyperostosis Frontalis Interna

metoclopramide has been researched along with Hyperostosis Frontalis Interna in 1 studies

Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Hyperostosis Frontalis Interna: Thickening of the inner table of the frontal bone, which may be associated with hypertrichosis and obesity. It most commonly affects women near menopause.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pawlikowski, M1
Komorowski, JM1

Other Studies

1 other study available for metoclopramide and Hyperostosis Frontalis Interna

ArticleYear
Hyperostosis frontalis and prolactin secretion.
    Experimental and clinical endocrinology, 1987, Volume: 89, Issue:1

    Topics: Adult; Female; Humans; Hyperostosis Frontalis Interna; Metoclopramide; Prolactin

1987